Minisymposia in Cardiovascular Medicine
Prof John-Bjarne Hansen, Department of Clinical Medicine, University of Tromsø, Norway
Title: ‘Interrelations between arterial and venous thromboembolic diseases’
John-Bjarne Hansen is is a clinical specialist and professor in hematology. He leads the K.G.Jebsen – Thrombosis Research and Expertise Center (TREC) which focus on inherited and non-inherited risk factors of venous thrombosis and to extend the understanding of the pathogenesis of venous thrombosis. He is the principal investigator of the Tromsø study, a North Norwegian population based cohort study that generated many recognized publications about epidemiology in venous thromboembolism.
John-Bjarne is assistant editor of Journal of Thrombosis and Haemostasis.
Dr David Trégouët, INSERM, Institute for Cardiometabolism and Nutrition, Pierre & Marie Curie Medical School, Paris, France
Title: ‘Novel insights into the (epi-)genetic epidemiology of arterial and venous thrombosis through the prism of high-throughput technologies’
David-Alexandre Trégouët is a world leader in the development of statistical tools and research strategies for the analysis of high-dimensional biological data generated by high-throughput technologies and their application to cardiovascular disease with a focus on venous thromboembolism. He belongs to the statistical core group of several international projects including MORGAM, EURAGEDIC, CardioGenics and CARDomics.
David is a member of the editorial board of the Arteriosclerosis Thrombosis and Vascular Biology, Human Genetics, Journal of Molecular Medicine and BMC Medical Genetics journals.
Host: Jacob Odeberg, Professor at KTH Royal Institute of Tehcnology and SciLifeLab faculty
In connection to the symposia MD Maria Bruzelius will defend her PhD-thesis November 13.
Time and venue: Lecture Hall, L8:00, CMM, Karolinska University Hospital, Solna
Title: Exploration of novel mechanisms and biomarkers for venous thromboembolism
– a genetics and proteomics study
Opponent: Professor John-Bjarne Hansen, University of Tromsø, Norway, Department of Clinical Medicine
Professor Eva Hellström-Lindberg, Karolinska Institutet, Department of Medicine Huddinge
Docent Masood Kamali-Moghaddam, Uppsala University, Department of Immunology, Genetics and Pathology
Docent Pelle Lindqvist, Karolinska Institutet, Department of Clinical Science,
Intervention and Technology
Professor Jacob Odeberg, Royal Institute of Technology (KTH), School of Biotechnology, Science for Life Laboratory Stockholm, Division of Proteomics
Karolinska Institutet. Department of Medicine Solna, Cardiovascular Medicine Unit
Professor Anders Hamsten, Karolinska Institutet. Department of Medicine Solna, Atherosclerosis Research Unit
Ph.D. Rona J. Strawbridge, Karolinska Institutet. Department of Medicine Solna, Cardiovascular Medicine Unit